Literature DB >> 19396443

PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major.

Bakela Nare1, Levi A Garraway, Tim J Vickers, Stephen M Beverley.   

Abstract

Leishmania must survive oxidative stress, but lack many classical antioxidant enzymes and rely heavily on trypanothione-dependent pathways. We used forward genetic screens to recover loci mediating oxidant resistance via overexpression in Leishmania major, which identified pteridine reductase 1 (PTR1). Comparisons of isogenic lines showed ptr1 (-) null mutants were 18-fold more sensitive to H(2)O(2) than PTR1-overproducing lines, and significant three- to fivefold differences were seen with a broad panel of oxidant-inducing agents. The toxicities of simple nitric oxide generators and other drug classes (except antifolates) were unaffected by PTR1 levels. H(2)O(2) susceptibility could be modulated by exogenous biopterin but not folate, in a PTR1- but not dihydrofolate reductase-dependent manner, implicating H(4)B metabolism specifically. Neither H(2)O(2) consumption nor the level of intracellular oxidative stress was affected by PTR1 levels. Coupled with the fact that reduced pteridines are at least 100-fold less abundant than cellular thiols, these data argue strongly that reduced pteridines act through a mechanism other than scavenging. The ability of unconjugated pteridines to counter oxidative stress has implications to infectivity and response to chemotherapy. Since the intracellular pteridine levels of Leishmania can be readily manipulated, these organisms offer a powerful setting for the dissection of pteridine-dependent oxidant susceptibility in higher eukaryotes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396443      PMCID: PMC2759280          DOI: 10.1007/s00294-009-0244-z

Source DB:  PubMed          Journal:  Curr Genet        ISSN: 0172-8083            Impact factor:   3.886


  68 in total

1.  Gene replacement in parasitic protozoa.

Authors:  A Cruz; S M Beverley
Journal:  Nature       Date:  1990-11-08       Impact factor: 49.962

Review 2.  Gene amplification in Leishmania.

Authors:  S M Beverley
Journal:  Annu Rev Microbiol       Date:  1991       Impact factor: 15.500

3.  Heavy metal resistance: a new role for P-glycoproteins in Leishmania.

Authors:  H L Callahan; S M Beverley
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

4.  Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor.

Authors:  M A Tayeh; M A Marletta
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

5.  Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.

Authors:  F Y Liew; S Millott; C Parkinson; R M Palmer; S Moncada
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

6.  Double targeted gene replacement for creating null mutants.

Authors:  A Cruz; C M Coburn; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

7.  Multiple drug resistance and conservative amplification of the H region in Leishmania major.

Authors:  T E Ellenberger; S M Beverley
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

8.  Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression.

Authors:  G M Kapler; C M Coburn; S M Beverley
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

Review 9.  Metabolism and functions of trypanothione in the Kinetoplastida.

Authors:  A H Fairlamb; A Cerami
Journal:  Annu Rev Microbiol       Date:  1992       Impact factor: 15.500

10.  On the mechanism of NO release from sydnonimines.

Authors:  M Feelisch; J Ostrowski; E Noack
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

View more
  12 in total

1.  Phenylalanine hydroxylase (PAH) from the lower eukaryote Leishmania major.

Authors:  Lon-Fye Lye; Song Ok Kang; Joshua D Nosanchuk; Arturo Casadevall; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2010-09-29       Impact factor: 1.759

Review 2.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

3.  Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice.

Authors:  Natasha Sienkiewicz; Han B Ong; Alan H Fairlamb
Journal:  Mol Microbiol       Date:  2010-06-01       Impact factor: 3.501

4.  FolX and FolM are essential for tetrahydromonapterin synthesis in Escherichia coli and Pseudomonas aeruginosa.

Authors:  Anne Pribat; Ian K Blaby; Aurora Lara-Núñez; Jesse F Gregory; Valérie de Crécy-Lagard; Andrew D Hanson
Journal:  J Bacteriol       Date:  2009-11-06       Impact factor: 3.490

5.  Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum.

Authors:  Arijit Bhattacharya; Philippe Leprohon; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2021-04-27

6.  Leishmania major methionine sulfoxide reductase A is required for resistance to oxidative stress and efficient replication in macrophages.

Authors:  Fiona M Sansom; Leonie Tang; Julie E Ralton; Eleanor C Saunders; Thomas Naderer; Malcolm J McConville
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

7.  Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major.

Authors:  Han B Ong; Natasha Sienkiewicz; Susan Wyllie; Alan H Fairlamb
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

Review 8.  Deception and manipulation: the arms of leishmania, a successful parasite.

Authors:  Pedro Cecílio; Begoña Pérez-Cabezas; Nuno Santarém; Joana Maciel; Vasco Rodrigues; Anabela Cordeiro da Silva
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

9.  Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.

Authors:  Lindsay B Tulloch; Viviane P Martini; Jorge Iulek; Judith K Huggan; Jeong Hwan Lee; Colin L Gibson; Terry K Smith; Colin J Suckling; William N Hunter
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

10.  LM14 defined medium enables continuous growth of Trypanosoma cruzi.

Authors:  Carla V De Paula Lima; Michel Batista; Fernanda G Kugeratski; Isabel M Vincent; Maurilio J Soares; Christian M Probst; Marco A Krieger; Fabricio K Marchini
Journal:  BMC Microbiol       Date:  2014-09-10       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.